Ironwood Pharmaceuticals

NASDAQ: IRWD
Developing and commercializing innovative medicines focused on gastrointestinal diseases.
Developing and commercializing innovative medicines focused on gastrointestinal diseases.

F-Prime Team

Sector

Life Sciences

Category

Therapeutics

Location

Cambridge, MA

Initial Investment

2002
Ironwood Pharmaceuticals

Ironwood Pharmaceuticals (NASDAQ: IRWD) developed linaclotide, a first-in-class therapy that received FDA approval for both irritable bowel syndrome and chronic constipation.